Integer Holdings Corporation Announces New Conversion Period
Integer Holdings Corporation (NYSE: ITGR), recognized as a leader in the medical device sector, has recently communicated significant news for holders of its 2.125% Convertible Senior Notes due 2028. Starting from July 1, 2025, and concluding on September 30, 2025, holders of these notes will have the opportunity to exercise their Conversion Option. This flexibility allows them to convert their notes into cash up to the principal amount and potentially shares of the company’s common stock.
Details of the Conversion Option
This conversion right was triggered as the shares of Integer Holdings consistently outperformed expectations. Specifically, if the last reported sale price of the company's common stock exceeds 130% of the conversion price for at least 20 trading days within 30 consecutive trading days leading to the end of the last quarter, the notes become convertible. This dynamic approach ensures that the conversion option aligns with market performance, providing holders with strategic timing to act.
Understanding the Conversion Mechanics
The conversion rate established for these notes stands at an impressive 11.4681 shares of common stock for every $1,000 principal amount of notes. Essentially, this equates to a conversion price around $87.20 per share. Such terms provide a compelling incentive for investors looking to engage with the company’s equity.
Notice and Procedures for Holders
Integer Holdings has circulated a notice detailing the terms, conditions, and the necessary procedures to exercise the Conversion Option. This notice is accessible through The Depository Trust Company, and interested parties can also reach out to Wilmington Trust, National Association, the designated conversion agent. Wilmington Trust can be contacted at their office address for inquiries related to the conversion process and further clarifications.
Company Outlook and Commitment
Integer Holdings Corporation stands at the forefront of medical device innovation. As one of the largest medical device contract development and manufacturing organizations worldwide, Integer dedicates itself to enriching patient lives through high-quality solutions. Their expertise spans various sectors, including cardiac rhythm management, neuromodulation, and cardiovascular markets, showcasing their versatility and commitment to excellence.
Continued Innovation and Market Position
With esteemed brands such as Greatbatch Medical and Lake Region Medical under its umbrella, Integer fortifies its position as a preferred partner for medical device companies and OEMs. The company continues to focus on innovative developments that enhance health solutions, with investor interests aligned with their long-term growth strategies and product offerings.
Investor Relations and Communication
Integer emphasizes transparency and effective communication with its stakeholders. For any questions or additional information regarding the Conversion Option, investors can contact Kristen Stewart for Investor Relations or Kelly Butler for Media Relations. The company is dedicated to making certain that all inquiries are met with detailed responses and support.
Contact Information
Kristen Stewart can be reached via email at kristen.stewart@integer.net, and her contact number is 551.337.3973. On the media side, Kelly Butler is available at kelly.butler@integer.net, with a direct line of 469.731.6617.
Frequently Asked Questions
What is the primary purpose of the Conversion Option announced?
The Conversion Option allows holders of the 2.125% Convertible Senior Notes to convert their securities into cash or shares of the company, thus aligning their investments with Integer's stock performance.
How does the conversion price influence my options?
The conversion price is critical as it determines how many shares you can obtain per dollar of your Notes’ principal amount. A favorable conversion price could result in significant returns for investors during the conversion period.
Where can I find more details on the conversion procedures?
Further information can be found in the notice issued by Integer Holdings, which is also accessible through The Depository Trust Company or by contacting Wilmington Trust directly.
What sectors does Integer Holdings focus on?
Integer Holdings specializes in advanced medical device solutions across cardiac rhythm management, neuromodulation, and cardiovascular markets, showcasing their extensive capabilities in enhancing patient care.
Who can investors contact for further inquiries?
Investors can reach out to Kristen Stewart for investor relations concerns or Kelly Butler for media inquiries. Their contact information is included in the announcement.
